Xiaoli Meng Selected Research

Xiaoli Meng Research Topics

Disease

20	Hypersensitivity (Allergy) 01/2023 - 06/2009
5	Chemical and Drug Induced Liver Injury 07/2023 - 01/2015
5	Drug Hypersensitivity (Drug Allergy) 01/2023 - 08/2014
3	Neoplasms (Cancer) 11/2023 - 01/2019
3	Drug-Related Side Effects and Adverse Reactions 01/2023 - 01/2007
3	Cystic Fibrosis (Mucoviscidosis) 06/2013 - 07/2011
2	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 10/2023
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 05/2002
1	Neoplasm Metastasis (Metastasis) 11/2023
1	Lymphatic Metastasis 11/2023
1	Skin Diseases (Skin Disease) 10/2023
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2023
1	Cholestasis 01/2023
1	Breast Neoplasms (Breast Cancer) 03/2022
1	Brain Neoplasms (Brain Tumor) 03/2022
1	Ischemic Stroke 01/2022
1	Ischemia 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2021
1	Eosinophilia 01/2021
1	Exanthema (Rash) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Agranulocytosis (Granulocytopenia) 11/2020
1	Immediate Hypersensitivity 10/2020
1	COVID-19 10/2020
1	Virus Diseases (Viral Diseases) 01/2019
1	Myopia 01/2019
1	Hepatitis C 01/2019
1	Iatrogenic Disease 01/2017
1	Dehydration (Water Stress) 01/2017
1	Tuberculosis (Tuberculoses) 01/2017
1	Marfan Syndrome (Marfan's Syndrome) 01/2012
1	Staphylococcal Infections 06/2009

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2011
6	AntigensIBA 10/2023 - 07/2011
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 06/2012
6	LactamsIBA 01/2023 - 06/2012
5	HaptensIBA 01/2023 - 09/2011
4	Dapsone FDA Link 01/2023 - 12/2017
4	Piperacillin FDA LinkGeneric 12/2017 - 07/2011
3	Peptides (Polypeptides)IBA 01/2023 - 06/2009
3	Amoxicillin (Wymox)FDA LinkGeneric 11/2020 - 10/2016
3	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 11/2020 - 10/2016
3	Penicillins (Penicillin)FDA Link 12/2017 - 06/2009
2	HLA-B Antigens (HLA-B)IBA 01/2023 - 01/2019
2	Floxacillin (Flucloxacillin)IBA 01/2023 - 06/2009
2	EpitopesIBA 01/2023 - 11/2022
2	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2022
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2019
2	Carbamazepine (Tegretol)FDA LinkGeneric 01/2021 - 01/2017
2	AntibodiesIBA 12/2017 - 01/2016
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2017 - 01/2015
2	Diclofenac (SR 38)FDA LinkGeneric 08/2014 - 01/2007
2	AlbuminsIBA 08/2014 - 06/2013
1	gallium 68 PSMA-11IBA 11/2023
1	N 30IBA 11/2023
1	ErbB Receptors (EGF Receptor)IBA 10/2023
1	HLA-C Antigens (HLA-C)IBA 10/2023
1	Ibuprofen (Motrin)FDA LinkGeneric 07/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2023
1	Naproxen (Naprosyn)FDA LinkGeneric 07/2023
1	Tolvaptan FDA Link 01/2023
1	Transaminases (Aminotransferases)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2022
1	CytokinesIBA 06/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	atabecestatIBA 01/2021
1	GlycopeptidesIBA 01/2021
1	LigandsIBA 01/2021
1	Vancomycin FDA LinkGeneric 01/2021
1	HLA-A Antigens (HLA-A)IBA 01/2021
1	Antipsychotic Agents (Antipsychotics)IBA 11/2020
1	Clozapine (Clozaril)FDA LinkGeneric 11/2020
1	Sulfamethoxazole FDA LinkGeneric 10/2019
1	telaprevirIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Ribavirin (Virazole)FDA LinkGeneric 01/2019
1	InterferonsIBA 01/2019
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 12/2017
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2017
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2017
1	OxidesIBA 01/2017
1	Pyrazinamide FDA LinkGeneric 01/2017
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2017
1	Protein SIBA 08/2014
1	GlucuronidesIBA 08/2014
1	SulfonamidesIBA 08/2014
1	4-phenylenediamine (p-phenylenediamine)FDA Link 08/2014
1	Reverse Transcriptase InhibitorsIBA 04/2014
1	NucleosidesIBA 04/2014
1	abacavir (Ziagen)FDA Link 04/2014
1	HLA-B57 antigenIBA 04/2014
1	Human Serum Albumin FDA LinkGeneric 06/2013
1	Aztreonam FDA LinkGeneric 06/2013
1	Meropenem (Merrem)FDA LinkGeneric 06/2013
1	Fibrillin-1IBA 01/2012
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2002

Therapy/Procedure

2	Therapeutics 10/2020 - 01/2017
1	Oral Administration 01/2007